222 related articles for article (PubMed ID: 15981222)
21. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
Della Porta MG; Lanza F; Del Vecchio L;
Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
[TBL] [Abstract][Full Text] [Related]
23. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
Zhang Y; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
25. [A feature of hematological findings in myelodysplastic syndromes].
Bando S; Niiya T; Murase M; Makino H
Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
[TBL] [Abstract][Full Text] [Related]
26. The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes.
Furundarena JR; Araiz M; Uranga M; Sainz MR; Agirre A; Trassorras M; Uresandi N; Montes MC; Argoitia N
Int J Lab Hematol; 2010 Jun; 32(3):360-6. PubMed ID: 19906272
[TBL] [Abstract][Full Text] [Related]
27. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.
Wells DA; Benesch M; Loken MR; Vallejo C; Myerson D; Leisenring WM; Deeg HJ
Blood; 2003 Jul; 102(1):394-403. PubMed ID: 12649150
[TBL] [Abstract][Full Text] [Related]
28. Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.
Somasundaram V; Soni S; Chopra A; Rai S; Mahapatra M; Kumar R; Pati H
Int J Lab Hematol; 2016 Apr; 38(2):141-50. PubMed ID: 26822549
[TBL] [Abstract][Full Text] [Related]
29. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
[TBL] [Abstract][Full Text] [Related]
30. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
[TBL] [Abstract][Full Text] [Related]
32. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
34. Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.
Hamada T; Matsuura H; Oono T; Morizane S; Yamasaki O; Asagoe K; Yamamoto T; Tsuji K; Iwatsuki K
Arch Dermatol; 2008 May; 144(5):643-8. PubMed ID: 18490591
[TBL] [Abstract][Full Text] [Related]
35. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
36. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
37. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
38. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
[TBL] [Abstract][Full Text] [Related]
40. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
Wang XQ;
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
